The General Use of Robots in Stroke Recovery: the Anklebot

Northwell Health55 enrolled

Overview

The purpose of this study is to determine if isolated robot-assisted training of the ankle joint improves chronic hemiparetic gait in patients after stroke.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Stroke

Interventions

seated robot-assisted ankle therapyDEVICE

The MIT anklebot provides over one thousand total dorsi/plantar flexion and inversion/eversion robot-assisted movements of the ankle while in a seated position.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older * First single focal unilateral lesion with diagnosis verified by brain imaging, which occurred at least 6 months prior * Cognitive function sufficient enough to understand experiments and follow instructions * Some amount of independent ambulation (with orthoses or walker) Exclusion Criteria: * Botox treatment within 6-weeks of enrollment; * Fixed contraction deformity in the affected limb; * Complete and total flaccid paralysis of all lower extremity motor function; * Unable to ambulate except with the aid of another person

Locations (2)

Feinstein Institutes for Medical Research

Manhasset, New York, United States

Transitions of Long Island Outpatient Rehabilitation

Manhasset, New York, United States

Outcomes

Primary Outcomes

Mean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Comfortable Pace.

Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean gait speeds on the 10m Walk Test at comfortable pace (m/sec) were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Time frame: baseline, discharge (week 6), 3 month FU (overall week 18)

Secondary Outcomes

Mean Change From Baseline in Gait Speed (m/Sec) on the 10 Meter Walk Test at Fast Pace.

Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean gait speeds on the 10m Walk Test at fast pace (m/sec) were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Time frame: baseline, discharge (week 6), 3 month FU (overall week 18)

Mean Change From Baseline in Distance Walked (Meters) on the 6 Minute Walk Test at Comfortable Pace.

Subjects were stratified based on average admission gait speed on the 10 Meter Walk Test at comfortable pace according to clinically established gait speed performance groups: low (\<0.4m/sec), moderate (0.4m/sec-0.8m/sec) and high (\>0.8m/sec) functioning. Mean distance walked (m) on the 6 Minute Walk test at comfortable pace were then compared across these three groups (low, moderate, and high function) at three timepoints (baseline, discharge (week 6), and 3 month FU (overall week 18)).

Time frame: baseline, discharge (week 6), 3 month FU (overall week 18)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.